Dementia Japan37:466-480, 2023

Transferrin biosynthesized by neurons is a diagnostic marker for Alzheimer’s disease

Yasuhiro Hashimoto1), Takashi Saito2), Yoshiki Yamaguchi3), Takashi Honda4)

1)Department of Neurosurgery, Fukushima Medical University School of Medicine
2)Department of Neurocognitive Science, Institute of Brain Science, Nagoya City University Graduate School of Medical Science
3)Division of Structural Glycobiology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University
4)Department of Human Life Science, Fukushima Medical University School of Nursing

Glycosylation is a cell type-specific post-translational modification that can be used for biomarker identification in various diseases. Aim of this study is to explore glycan-biomarkers on transferrin (Tf) for Alzheimer’s disease (AD) in cerebrospinal fluid (CSF). Glycan structures of CSF Tf were analyzed by ultra-performance liquid chromatography followed by mass spectrometry. We found that a unique mannosylated-glycan is carried by a Tf isoform in CSF (Man-Tf). The cerebral cortex contained Man-Tf as a major isoform, suggesting that CSF Man-Tf is, at least partly, derived from the cortex. Man-Tf levels were analyzed in CSF of patients with neurological diseases. Concentrations of Man-Tf were significantly increased in AD and mild cognitive impairment (MCI) comparing with other neurological diseases, and the levels correlated well with those of phosphorylated-tau (p-tau), a representative AD marker. Consistent with the observation, p-tau and Tf were co-expressed in hippocampal neurons of AD, leading to the notion that a combined p-tau and Man-Tf measure could be a biomarker for AD. Indeed, levels of p-tau x Man-Tf showed high diagnostic accuracy for MCI and AD;84% sensitivities and 90% specificities for MCI and 94% sensitivities and 89% specificities for AD. Thus Man-Tf could be a new biomarker for AD.


Address correspondence to Dr. Yasuhiro Hashimoto, Department of Neurosusrgery, Fukushima Medical University School of Medicine (1 Hikarigaoka, Fukushima-City, Fukushima 960-1295, Japan)